{"gene":"TRAF1","run_date":"2026-06-10T10:51:55","timeline":{"discoveries":[{"year":1998,"finding":"NF-κB transcriptionally induces TRAF1, TRAF2, c-IAP1, and c-IAP2; these proteins act cooperatively to suppress caspase-8 activation and block TNF-α-mediated apoptosis at the earliest checkpoint.","method":"NF-κB reporter assays, cotransfection/overexpression, caspase-8 activation assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional experiments with reporter assays and caspase activity readouts, widely replicated across subsequent literature","pmids":["9733516"],"is_preprint":false},{"year":1996,"finding":"TRAF1, TRAF2, and TRAF3 bind a single PXQXT/S core motif in the LMP1 cytoplasmic C-terminus (aa 199–214); in EBV-transformed B cells most TRAF1 and TRAF3 is associated with LMP1. TRAF1 coactivates NF-κB with LMP1 via TRAF1/TRAF2 heteroaggregates; dominant-negative TRAF2 blocks this, and TRAF3 is a negative modulator.","method":"Co-immunoprecipitation, alanine/deletion mutagenesis, NF-κB reporter cotransfection, EBV-transformed B cell fractionation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — mutagenesis mapping + reciprocal co-IP in primary EBV-transformed cells, replicated by multiple labs","pmids":["8943365"],"is_preprint":false},{"year":1996,"finding":"A20 interacts with the conserved C-terminal TRAF domain of TRAF1 and TRAF2 via its N-terminal half; A20's C-terminal zinc finger domain inhibits TRAF2-mediated NF-κB activation, identifying a two-domain feedback inhibitor recruited to the TRAF1/TRAF2 complex.","method":"Co-immunoprecipitation, deletion/mutational analysis, NF-κB reporter cotransfection assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal binding assays with mutagenesis, functional NF-κB readout, replicated by other labs","pmids":["8692885"],"is_preprint":false},{"year":1997,"finding":"CD30 cytoplasmic domain contains two TRAF-binding motifs: membrane-proximal motif 576MLSVEEEG583 binds TRAF1 and TRAF2, while 558PHYPEQET565 binds TRAF2 and TRAF3. Coexpression of TRAF1 or TRAF2 (but not TRAF3) augments CD30 domain 2-mediated NF-κB activation; dominant-negative TRAF1 or TRAF2 inhibits this.","method":"Yeast two-hybrid, co-immunoprecipitation, NF-κB reporter cotransfection, deletion/dominant-negative analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus reciprocal co-IP plus functional NF-κB assay with dominant negatives, independently confirmed by multiple labs","pmids":["9032281","9168896","8943059"],"is_preprint":false},{"year":2010,"finding":"Crystal structures of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2 complexes show that a TRAF2 trimer contacts cIAP2 via two chains; TRAF1 and TRAF2 preferentially form a TRAF1:(TRAF2)₂ heterotrimer that binds cIAP2 more strongly than TRAF2 alone. TRAF1 alone binds cIAP2 very weakly. Key interface residues confirmed by mutagenesis.","method":"X-ray crystallography, solution binding assays, site-directed mutagenesis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with mutagenesis validation in single rigorous study","pmids":["20385093"],"is_preprint":false},{"year":2001,"finding":"TRAF1-deficient mice show enhanced TNF signaling: TRAF1⁻/⁻ T cells respond to TNF via TNFR2 (p75) but not TNFR1 (p55) with hyperproliferation and elevated NF-κB/AP-1 activity, and skin is hypersensitive to TNF-induced necrosis, demonstrating TRAF1 is a negative regulator of TNFR2-mediated TNF signaling.","method":"Knockout mouse generation, T cell proliferation assays, NF-κB/AP-1 signaling assays, in vivo skin necrosis model","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with multiple orthogonal phenotypic readouts and receptor specificity defined","pmids":["11672546"],"is_preprint":false},{"year":2002,"finding":"TRAF1 displaces TRAF2 from lipid rafts/detergent-insoluble fractions and prevents stimulus-dependent TRAF2 degradation, thereby sustaining TRAF2-dependent signaling over time. TRAF1⁻/⁻ dendritic cells show attenuated responses to secondary TRAF2-dependent stimulation and increased TRAF2 degradation.","method":"Lipid raft fractionation, co-immunoprecipitation, TRAF1-KO dendritic cell signaling assays, RING-finger domain swap constructs","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (fractionation, KO cells, domain swap) in single study","pmids":["12370254"],"is_preprint":false},{"year":2000,"finding":"TRAF1 (but not TRAF2–6) is cleaved by caspase-8 at site ¹⁶⁰LEVD¹⁶³ during TNF-α- and Fas-induced apoptosis, generating a C-terminal fragment that suppresses NF-κB activation and enhances TNF receptor-1-mediated apoptosis.","method":"In vitro caspase cleavage assays, in vivo apoptosis induction, site-directed mutagenesis of cleavage site, NF-κB reporter assays, overexpression in HEK293T and HT1080 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro cleavage mapping with mutagenesis plus in vivo confirmation and functional readout","pmids":["11098060"],"is_preprint":false},{"year":2000,"finding":"TRAF1 is cleaved after Asp-163 during Fas ligand-induced apoptosis; the C-terminal cleavage product acts as a dominant-negative form of TRAF1 that blocks TNF-induced NF-κB activation, providing a pro-apoptotic amplification mechanism.","method":"Apoptosis induction, Western blot cleavage analysis, NF-κB reporter assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, functional reporter assay; corroborates PMID 11098060 finding","pmids":["10692572"],"is_preprint":false},{"year":2003,"finding":"Caspase-derived C-terminal TRAF1 fragment (TRAF1-164–416) acts as a general inhibitor of NF-κB activation by directly associating with the IKK complex via the N-TRAF domain, whereas full-length TRAF1 modulates NF-κB differentially across TNF receptors. Full-length TRAF1 and the cleavage fragment are both constitutively associated with IKK.","method":"Co-immunoprecipitation with IKK complex, NF-κB reporter assays, IKK kinase assays, overexpression of TRAF domain fragments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with IKK plus kinase assay plus functional reporter, single lab","pmids":["12709429"],"is_preprint":false},{"year":2001,"finding":"Caspase-8-generated C-terminal TRAF1 fragment co-immunoprecipitates with TRAF2 released from the TNFR1 complex during prolonged TNF treatment, sequestering TRAF2 and thereby reducing its anti-apoptotic signaling.","method":"Co-immunoprecipitation from TNF-stimulated cells, overexpression of TRAF1-c fragment, cell death assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single co-IP experiment in intact cells corroborating prior cleavage findings","pmids":["11181075"],"is_preprint":false},{"year":1999,"finding":"TRAF1 promoter contains functional NF-κB binding sites; TNF-R1, CD40, and IL-1R trigger NF-κB-dependent TRAF1 transcription. Overexpressed TRAF1 prolongs TNF-induced JNK activation while a deletion mutant lacking the N-terminal region inhibits TNF-induced NF-κB and JNK activation.","method":"EMSA, promoter-reporter gene assays, RNase protection, transfection of deletion mutants","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA + promoter reporter + dominant-negative functional assay in single lab","pmids":["10383449"],"is_preprint":false},{"year":1999,"finding":"Overexpression of TRAF1 in HEK293T cells completely prevented NF-κB activation induced by TNF, IL-1, overexpression of TRAF2, or TRAF6, identifying TRAF1 as a negative regulator of NF-κB pathways. TNF-induced TRAF1 upregulation was blocked by the proteasome inhibitor MG-132.","method":"Transfection/overexpression, NF-κB reporter assays, pharmacological inhibition","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — functional reporter assay with overexpression, single lab","pmids":["10544244"],"is_preprint":false},{"year":2008,"finding":"TRAF1 is required for 4-1BB-mediated CD8 T cell survival in vivo; TRAF1-deficient CD8 T cells fail to activate ERK downstream of 4-1BB, show reduced Bcl-xL upregulation and elevated Bim, resulting in impaired survival during viral infection. ERK inhibition downstream of 4-1BB in wild-type cells phenocopies TRAF1 deficiency.","method":"TRAF1-KO mice, viral infection models, intracellular signaling assays (ERK activation), Bcl-xL/Bim Western blot, pharmacological ERK inhibition","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO in vivo model with orthogonal pharmacological validation and defined molecular pathway","pmids":["18523273"],"is_preprint":false},{"year":2012,"finding":"TRAF1 is required for maximal classical NF-κB activation downstream of 4-1BB; TRAF1 also restricts constitutive NIK activity in activated T cells by participating in the cIAP1/2:TRAF2:TRAF3:NIK complex. 4-1BB stimulation induces cIAP1-dependent TRAF3 degradation to activate the alternative NF-κB pathway, and this requires TRAF1.","method":"siRNA knockdown of NIK, TRAF1-KO primary T cells, NF-κB pathway reporter assays, Western blot for NIK/TRAF3/cIAP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO plus siRNA epistasis with multiple pathway readouts in single rigorous study","pmids":["22570473"],"is_preprint":false},{"year":2013,"finding":"Increased neuronal TRAF1 after stroke correlates with elevated neuronal death and enlarged ischemic lesions; TRAF1 deficiency is neuroprotective. TRAF1 directly interacts with ASK1 to activate the JNK pro-death pathway and inhibit the Akt survival pathway.","method":"Genetic KO/overexpression in mouse stroke model, co-immunoprecipitation for TRAF1-ASK1 interaction, JNK and Akt pathway Western blots","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic approaches plus direct co-IP demonstrating TRAF1-ASK1 physical interaction with pathway readouts","pmids":["24284943"],"is_preprint":false},{"year":2016,"finding":"TRAF1 promotes hepatic steatosis, insulin resistance, and inflammation through enhancing ASK1-mediated P38/JNK cascade activation; ASK1 inhibition abolishes these effects. Demonstrated using TRAF1-KO and liver-specific TRAF1 overexpression mice.","method":"Global TRAF1 KO and liver-specific overexpression mouse models, HFD/ob-ob obesity models, in vivo ASK1 inhibitor treatment, P38/JNK pathway Western blots","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic gain- and loss-of-function with pharmacological epistasis confirming TRAF1→ASK1 axis","pmids":["26860405"],"is_preprint":false},{"year":2016,"finding":"The TRAF1 MATH domain binds directly to three LUBAC components (SHARPIN, HOIP, HOIL-1), interfering with NEMO linear ubiquitination and thereby decreasing NF-κB activation and cytokine production independently of TNF. This negative regulation of TLR signaling is distinct from its TNFR superfamily role.","method":"Direct binding assays, co-immunoprecipitation of TRAF1-LUBAC complex, NEMO ubiquitination assays, Traf1-KO mice in LPS septic shock model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding mapping with co-IP, functional ubiquitination assay, and in vivo KO validation; single lab but multiple orthogonal methods","pmids":["27893701"],"is_preprint":false},{"year":2015,"finding":"LMP1 TES1 domain signaling induces TRAF1 association with LUBAC and stimulates M1-linked polyubiquitin chain attachment to TRAF1 complexes; TRAF2 (but not cIAP1/2) is required for LUBAC recruitment. LMP1/TRAF1 complexes are also decorated by K63-linked polyubiquitin chains, and TRAF2 is a K63-Ub chain target. TRAF1 depletion markedly impairs LCL growth.","method":"Proteomic analysis of immunopurified TRAF1 complexes, M1/K63 polyubiquitin chain detection, TRAF1/HOIP knockdown with proliferation assays","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mass spectrometry interactome plus orthogonal ubiquitin chain assays plus functional knockdown readout","pmids":["25996949"],"is_preprint":false},{"year":2006,"finding":"TRAF1 interacts with the TIR domain adaptor TRIF via its TRAF-C domain; overexpression of TRAF1 inhibits TRIF- and TLR3-mediated NF-κB, ISRE, and IFN-β promoter activation. TRIF overexpression causes caspase-dependent cleavage of TRAF1; the cleaved N-terminal fragment (but not C-terminal) mediates inhibition, and mutation of the caspase cleavage site abolishes inhibition.","method":"Yeast two-hybrid, co-immunoprecipitation, domain mapping, NF-κB/ISRE/IFN-β reporter assays, caspase cleavage mutants","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus mutagenesis with functional reporters, single lab","pmids":["16323247"],"is_preprint":false},{"year":2003,"finding":"TRAF1 critically regulates TRAF2-dependent JNK activation downstream of LMP1 TRAF-binding domain in a cell-type-specific manner; in TRAF1-negative epithelial cells reconstitution of TRAF1 expression restores LMP1-induced JNK activation. This TRAF1 requirement is specific to LMP1's TRAF-binding domain and is not shared by CD40's homologous region.","method":"TRAF1-positive vs -negative cell lines, TRAF1 reconstitution, dominant-negative TRAF constructs, JNK kinase assays","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type comparison with reconstitution and dominant-negative epistasis, single lab","pmids":["12502848"],"is_preprint":false},{"year":2008,"finding":"PKN1 phosphorylates TRAF1 in vitro and in vivo; this phosphorylation is required to attenuate constitutive IKK/JNK activity in unstimulated cells. Mutation of the TRAF1 phospho-acceptor residue abrogates PKN1-dependent TRAF1 recruitment to TNFR2. The stoichiometric ratio of TRAF1:TRAF2 heteromeric complexes at TNFR2 controls tonic JNK and IKK activity.","method":"In vitro kinase assay with PKN1 and TRAF1, in vivo phosphorylation analysis, phospho-acceptor mutagenesis, co-immunoprecipitation with TNFR2, IKK/JNK activity assays","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Weak — in vitro kinase assay plus in vivo phosphorylation plus mutagenesis, but single lab","pmids":["18429822"],"is_preprint":false},{"year":2004,"finding":"Phorbol ester-mediated TRAF1 induction in colon cancer cells proceeds through a Ca²⁺-dependent PKC/Raf-1/MEK/ERK/NF-κB pathway; site-specific mutagenesis of NF-κB sites in the TRAF1 promoter (especially the most proximal site) significantly decreases phorbol ester-driven TRAF1 transcription.","method":"PKC inhibitors, MEK/ERK inhibitors, dominant-negative Raf-1 transfection, NF-κB site mutagenesis in TRAF1 promoter-reporter constructs","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibitors plus dominant-negative plus promoter mutagenesis, single lab","pmids":["14981539"],"is_preprint":false},{"year":1997,"finding":"Overexpression of TRAF1 in transgenic mice inhibits antigen-induced apoptosis of CD8⁺ T lymphocytes, establishing a biological role for TRAF1 as a regulator of apoptotic signals downstream of TNFR2.","method":"TRAF1 transgenic mice, antigen-induced apoptosis assay in CD8 T cells","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic gain-of-function model with defined apoptosis readout, single lab","pmids":["9151703"],"is_preprint":false},{"year":2005,"finding":"TRAF1 associates with NIP45 (NFAT-interacting protein) in the cytoplasm and prevents its nuclear translocation; TRAF1-deficient T cells show elevated nuclear NIP45 and increased Th2 cytokine production, indicating TRAF1 limits Th2 differentiation by retaining NIP45 in the cytoplasm.","method":"TRAF1-KO mouse model, Th2 cytokine measurement, subcellular fractionation/nuclear NIP45 Western blot, in vitro T cell stimulation","journal":"International immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus biochemical co-localization with defined functional consequence, single lab","pmids":["16352630"],"is_preprint":false},{"year":2000,"finding":"CD40 engagement induces TRAF1 gene transcription in B lymphocytes through two enhancer regions: an upstream region (~2 kb from start site) containing a single critical NF-κB site (mutation abolishes CD40-driven TRAF1 transcription) and an intronic enhancer (between exons 5 and 6) with NF-κB and AP-1 sites.","method":"CD40 ligation, reporter gene assays, NF-κB/AP-1 site mutagenesis, B lymphocyte transfections","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mutagenesis with functional reporter, single lab","pmids":["11395135"],"is_preprint":false},{"year":2016,"finding":"Crystal structure of the TRAF1 TRAF domain (TRAF-N coiled-coil + TRAF-C) reveals that the TRAF-N coiled-coil domain is critical for trimer formation and protein stability; conserved TRAF-C surface residues constitute binding hotspots for interaction with signaling molecules.","method":"X-ray crystallography, biochemical trimer formation assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure of isolated domain, single lab, limited mutagenesis","pmids":["27151821"],"is_preprint":false},{"year":2017,"finding":"Crystal structure of TRAF1 TRAF domain in complex with TANK peptide shows TANK binds TRAF1 using the minor consensus motif Px(Q/E)xT; quantitative binding experiments show TANK interacts with TRAF1 and TRAF2 with similar micromolar affinity.","method":"X-ray crystallography (PDB: 5H10), quantitative binding assays","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structure with quantitative binding, single lab, no mutagenesis validation","pmids":["28155233"],"is_preprint":false},{"year":2018,"finding":"TRAF1 is critical for solar UV-induced ERK5 phosphorylation and AP-1 (c-Fos/c-Jun) expression in skin carcinogenesis; TRAF1 enhances ubiquitination of ERK5 on lysine 184, which is necessary for ERK5 kinase activity. TRAF1-KO mice show significant inhibition of skin tumor formation.","method":"TRAF1-KO mouse carcinogenesis model, ERK5 ubiquitination assays, phosphorylation/AP-1 Western blots, site-specific ubiquitin acceptor mutagenesis","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in vivo model with ERK5 ubiquitination mapping, single lab","pmids":["28131816"],"is_preprint":false},{"year":2018,"finding":"TRAF1 affects TRAF2-mediated K48-linked ubiquitination of BRAF; loss of TRAF1 decelerated tumor invasion in a urethane-induced lung carcinogenesis model, positioning TRAF1 as a regulator of the BRAF/MEK/ERK signaling pathway in NSCLC.","method":"TRAF1 overexpression/knockdown in cancer cells, ubiquitination assays for BRAF, in vivo lung carcinogenesis mouse model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ubiquitination assay plus in vivo KO tumor model, single lab","pmids":["29748372"],"is_preprint":false},{"year":2010,"finding":"TRAF1 interacts with IKK2 (identified by yeast two-hybrid using IKK2 C-terminal aa 466–756 as bait, binding TRAF1 N-terminal aa 1–228); confirmed by mammalian two-hybrid and co-immunoprecipitation. TRAF1 can both activate and inhibit IKK2 and NF-κB depending on dose; TRAF1 affects TRAF2 clustering in a dose-dependent manner.","method":"Yeast two-hybrid, mammalian two-hybrid, co-immunoprecipitation, NF-κB reporter assays, fluorescence-tagged co-expression","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two-hybrid plus co-IP plus functional assays, single lab","pmids":["20856938"],"is_preprint":false},{"year":2010,"finding":"TRAF1 deficiency in TRAF1⁻/⁻/LDLR⁻/⁻ mice attenuates atherosclerosis; mechanistically, TRAF1 deficiency in endothelial cells and monocytes reduces cell adhesion, actin polymerization, CD29 expression, and ICAM-1/VCAM-1 expression. Bone marrow transplantation reveals contributions from both hematopoietic and vascular resident TRAF1.","method":"Double-KO mouse atherosclerosis model, bone marrow transplantation, static/dynamic adhesion assays, siRNA in human cells","journal":"Circulation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus BM transplantation plus siRNA mechanistic validation, single lab","pmids":["20421522"],"is_preprint":false},{"year":2010,"finding":"TRAF1 mRNA translation is regulated by an IRES element located within 572 nt upstream of the AUG start codon (critical element between nt −392 and −322); vincristine induces TRAF1 protein expression by regulating cytoplasmic localization of polypyrimidine tract binding protein to stimulate IRES-dependent translation.","method":"Reporter assays with IRES-containing 5'-UTR constructs, deletion mapping, polypyrimidine tract binding protein cytoplasmic localization assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with deletion mapping plus mechanistic protein localization link, single lab","pmids":["20413583"],"is_preprint":false},{"year":2013,"finding":"A novel TRAF1-ALK fusion transcript (TRAF1 exon 6 fused to ALK exon 20) was identified in an anaplastic large cell lymphoma patient; the fusion protein was confirmed by Western blot, indicating TRAF1 can function as an ALK fusion partner driving lymphoma.","method":"Deep RNA sequencing, Sanger sequencing confirmation, Western blot for fusion protein","journal":"Genes, chromosomes & cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — single patient discovery, fusion protein confirmed by Western blot, no functional mechanistic studies in this paper","pmids":["23999969"],"is_preprint":false},{"year":2007,"finding":"TRAF1 deficiency in endothelial cells enhances CD40L-induced IL-6 and MCP-1 expression, while TRAF2 and TRAF5 deficiency inhibit CD40L-inducible IL-6 but not MCP-1, demonstrating that TRAF1 has a negative regulatory role in CD40 signaling in endothelial cells.","method":"Endothelial cells from TRAF-1, -2, -5-deficient mice, cytokine ELISA, gene silencing in human ECs","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO cells plus siRNA in human cells with cytokine readout, single lab","pmids":["17332487"],"is_preprint":false},{"year":2014,"finding":"DNMT3L forms a complex with DNMT3B and NF-κB p65 that controls DNA methylation at the TRAF1 promoter; TET3 is involved in demethylation of TRAF1, demonstrating dynamic methylation control of the TRAF1 locus.","method":"TF array binding assays, co-immunoprecipitation of DNMT3L/DNMT3B/p65 complex, bisulfite sequencing of TRAF1 promoter, TET3 functional assays","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — complex co-IP plus bisulfite sequencing, single lab","pmids":["24952347"],"is_preprint":false},{"year":2011,"finding":"TGF-β induces posttranslational loss of TRAF1 protein from CD8 T cells, while IL-7 restores TRAF1 levels; loss of TRAF1 correlates with desensitization of 4-1BB signaling and T cell exhaustion during chronic LCMV infection. Transfer of TRAF1⁺ but not TRAF1⁻ memory T cells reduces viral load.","method":"Cytokine treatment of primary T cells with TRAF1 Western blot, LCMV chronic infection model, adoptive T cell transfer","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo LCMV model plus cytokine mechanistic studies plus adoptive transfer, single lab","pmids":["22184633"],"is_preprint":false}],"current_model":"TRAF1 is a RING finger-lacking adaptor protein that forms TRAF1:(TRAF2)₂ heterotrimers and associates with TNFR superfamily members (TNFR2, CD30, CD40, 4-1BB, LMP1) via a PXQXT/S motif; it modulates canonical and alternative NF-κB, JNK, ERK, and Akt pathways both positively (sustaining TRAF2 stability and 4-1BB→ERK→Bcl-xL survival signals) and negatively (competing with TRAF2 at receptors, sequestering LUBAC from NEMO to dampen TLR-driven NF-κB, and generating a dominant-negative caspase-8 cleavage fragment that suppresses NF-κB and amplifies apoptosis), and also directly binds ASK1 to promote JNK-mediated cell death in ischemic and inflammatory contexts."},"narrative":{"mechanistic_narrative":"TRAF1 is a RING finger-lacking adaptor of the TRAF family that couples TNF receptor superfamily members to NF-κB, JNK, ERK, and apoptotic signaling, acting as both a positive and negative modulator depending on receptor and dose [PMID:11672546, PMID:10544244]. It binds TNFR superfamily members and viral mimics through a PXQXT/S-type core motif, engaging LMP1, CD30, and other receptors, where it coactivates NF-κB largely as part of TRAF1/TRAF2 heteroaggregates [PMID:8943365, PMID:9032281, PMID:9168896, PMID:8943059]. Structurally, TRAF1 preferentially assembles into a TRAF1:(TRAF2)₂ heterotrimer whose TRAF-N coiled-coil drives trimerization and stability and whose TRAF-C surface forms the binding hotspot for partners such as cIAP2 and TANK; TRAF1 alone binds cIAP2 weakly, so its activity is largely exerted through TRAF2 [PMID:20385093, PMID:27151821, PMID:28155233]. As a transcriptional target induced by NF-κB downstream of TNFR1, CD40, and IL-1R, TRAF1 participates with TRAF2 and cIAP1/2 in suppressing caspase-8 activation and blocking early TNF-induced apoptosis, and it stabilizes TRAF2 by displacing it from lipid rafts to sustain signaling over time [PMID:9733516, PMID:12370254, PMID:11395135]. TRAF1 sets the threshold of multiple pathways: it restricts TNFR2-driven hyperproliferation and TNF-induced necrosis, dampens TLR-driven NF-κB by sequestering LUBAC components away from NEMO-directed linear ubiquitination, and limits constitutive NIK activity within the cIAP1/2:TRAF2:TRAF3:NIK complex [PMID:11672546, PMID:22570473, PMID:27893701]. In CD8 T cells it is required for 4-1BB–driven ERK activation, Bcl-xL induction, and survival, defining a costimulatory survival function [PMID:18523273]. Apoptotic caspase-8 cleavage at Asp-163 converts TRAF1 into a C-terminal dominant-negative fragment that associates with the IKK complex and sequesters released TRAF2, suppressing NF-κB and amplifying death signaling [PMID:11098060, PMID:12709429, PMID:11181075]. TRAF1 also directly binds ASK1 to drive JNK-mediated, Akt-suppressing cell death in ischemic stroke and metabolic/inflammatory liver disease [PMID:24284943, PMID:26860405].","teleology":[{"year":1996,"claim":"Established that TRAF1 is recruited to receptor cytoplasmic tails through a defined short linear motif and signals as part of TRAF1/TRAF2 heteroaggregates, defining its mode of receptor engagement.","evidence":"Co-IP, mutagenesis mapping of the PXQXT/S motif in LMP1 and CD30, and NF-κB reporter assays in EBV-transformed B cells","pmids":["8943365","9032281","9168896","8943059"],"confidence":"High","gaps":["Did not resolve stoichiometry or structural basis of TRAF1:TRAF2 heteromers","Receptor selectivity rules between TRAF1, TRAF2, and TRAF3 not fully defined"]},{"year":1996,"claim":"Identified A20 as a feedback inhibitor recruited to the TRAF1/TRAF2 complex, embedding TRAF1 in a negative-regulatory circuit of NF-κB.","evidence":"Co-IP, deletion analysis, and NF-κB reporter assays","pmids":["8692885"],"confidence":"High","gaps":["Direct contribution of TRAF1 (versus TRAF2) to A20 docking unresolved"]},{"year":1998,"claim":"Placed TRAF1 in a cooperative anti-apoptotic module that blocks caspase-8 activation at the earliest TNF checkpoint, linking it functionally to cell survival.","evidence":"NF-κB reporter assays, cotransfection with TRAF2/cIAP1/cIAP2, and caspase-8 activation assays","pmids":["9733516"],"confidence":"High","gaps":["Relative contribution of TRAF1 within the four-protein module not dissected","Mechanism of caspase-8 suppression not defined at molecular level"]},{"year":2000,"claim":"Showed that caspase cleavage at Asp-163 converts TRAF1 into a dominant-negative fragment, revealing a switch that amplifies apoptosis by suppressing NF-κB.","evidence":"In vitro caspase-8 cleavage mapping, cleavage-site mutagenesis, in vivo apoptosis, and NF-κB reporter assays","pmids":["11098060","10692572"],"confidence":"High","gaps":["Endogenous abundance and kinetics of the fragment in physiological apoptosis unclear"]},{"year":2001,"claim":"Defined TRAF1 as a negative regulator restricting TNFR2-specific TNF signaling in vivo, distinguishing receptor-selective roles.","evidence":"TRAF1-KO mice, T cell proliferation and NF-κB/AP-1 assays, TNFR1/TNFR2 receptor discrimination, and in vivo skin necrosis model","pmids":["11672546"],"confidence":"High","gaps":["Molecular basis of TNFR2 versus TNFR1 selectivity not resolved"]},{"year":2002,"claim":"Explained one positive function: TRAF1 sustains signaling by displacing TRAF2 from lipid rafts and preventing its stimulus-dependent degradation.","evidence":"Lipid raft fractionation, co-IP, TRAF1-KO dendritic cells, and RING-domain swap constructs","pmids":["12370254"],"confidence":"High","gaps":["Degradation machinery acting on TRAF2 not identified","How TRAF1 mechanistically blocks TRAF2 turnover unresolved"]},{"year":2003,"claim":"Mapped the cleavage fragment's inhibitory mechanism to direct constitutive association with the IKK complex via the N-TRAF domain.","evidence":"Co-IP with IKK, IKK kinase assays, NF-κB reporters, and TRAF-domain fragment overexpression","pmids":["12709429"],"confidence":"Medium","gaps":["Single lab; physiological relevance of constitutive IKK association not validated in primary cells","Precise IKK subunit contact not defined"]},{"year":2008,"claim":"Defined a costimulatory survival function: TRAF1 is required for 4-1BB→ERK→Bcl-xL signaling that sustains CD8 T cell survival.","evidence":"TRAF1-KO mice, viral infection, ERK activation and Bcl-xL/Bim Westerns, and pharmacological ERK inhibition phenocopy","pmids":["18523273"],"confidence":"High","gaps":["Direct link between TRAF1 and ERK activation machinery not biochemically mapped"]},{"year":2010,"claim":"Provided the structural basis for TRAF1's TRAF2-dependent activity, showing TRAF1:(TRAF2)₂ heterotrimers bind cIAP2 strongly while TRAF1 alone binds weakly.","evidence":"X-ray crystallography of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2, solution binding, and interface mutagenesis","pmids":["20385093"],"confidence":"High","gaps":["Structures of TRAF1 bound to receptor tails not solved","Dynamics of heterotrimer assembly in cells not addressed"]},{"year":2012,"claim":"Showed TRAF1 tunes both canonical and alternative NF-κB by enabling 4-1BB-driven classical activation while restricting constitutive NIK within the cIAP:TRAF2:TRAF3:NIK complex.","evidence":"TRAF1-KO primary T cells, NIK siRNA epistasis, and NIK/TRAF3/cIAP Westerns with reporter assays","pmids":["22570473"],"confidence":"High","gaps":["Stoichiometric control of NIK degradation by TRAF1 not quantified"]},{"year":2013,"claim":"Identified a direct TRAF1–ASK1 interaction driving JNK-mediated death and Akt suppression, extending TRAF1 function to ischemic neuronal injury.","evidence":"Genetic KO/overexpression in mouse stroke model, TRAF1-ASK1 co-IP, and JNK/Akt Westerns","pmids":["24284943"],"confidence":"High","gaps":["ASK1-binding region of TRAF1 not mapped","Whether TRAF2 is required for the ASK1 interaction unresolved"]},{"year":2016,"claim":"Established that the TRAF1 MATH/TRAF-C domain binds LUBAC components to interfere with NEMO linear ubiquitination, defining a TNFR-independent brake on TLR-driven NF-κB.","evidence":"Direct binding assays to SHARPIN/HOIP/HOIL-1, co-IP, NEMO ubiquitination assays, and Traf1-KO LPS septic shock model","pmids":["27893701"],"confidence":"High","gaps":["Quantitative competition between TRAF1 and NEMO for LUBAC not measured"]},{"year":2016,"claim":"Extended the TRAF1→ASK1 axis to metabolic disease, showing TRAF1 promotes hepatic steatosis and insulin resistance via ASK1-dependent P38/JNK activation.","evidence":"Global KO and liver-specific overexpression mice, obesity models, and in vivo ASK1 inhibitor epistasis","pmids":["26860405"],"confidence":"High","gaps":["Cell-type-specific contributions to hepatic phenotype not fully separated"]},{"year":2018,"claim":"Linked TRAF1 to oncogenic kinase signaling by promoting ERK5 K184 ubiquitination and TRAF2-mediated BRAF ubiquitination in carcinogenesis models.","evidence":"TRAF1-KO carcinogenesis models, ERK5/BRAF ubiquitination assays, and ubiquitin-acceptor mutagenesis","pmids":["28131816","29748372"],"confidence":"Medium","gaps":["TRAF1 lacks intrinsic ubiquitin ligase activity; the responsible E3 (likely TRAF2/cIAP) not definitively assigned","Single-lab findings per tumor context"]},{"year":null,"claim":"How TRAF1 dose, phosphorylation, and partner composition switch it between positive and negative signaling at a given receptor remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model integrating TRAF1:TRAF2 stoichiometry, PKN1 phosphorylation, and receptor context","Structures of full-length receptor-bound TRAF1 complexes lacking","In vivo relevance of caspase-cleavage fragment versus full-length TRAF1 not delineated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,3,4,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,12,14,17]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4,26]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[24,6]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,5,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[13,17,36]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,7,15,23]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[28,29,18]}],"complexes":["TRAF1:(TRAF2)2 heterotrimer","cIAP1/2:TRAF2:TRAF3:NIK complex","LUBAC (SHARPIN/HOIP/HOIL-1) associated complex","IKK complex"],"partners":["TRAF2","CIAP2","ASK1","HOIP","TANK","NIP45","IKK2","TRIF"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13077","full_name":"TNF receptor-associated factor 1","aliases":["Epstein-Barr virus-induced protein 6"],"length_aa":416,"mass_kda":46.2,"function":"Adapter molecule that regulates the activation of NF-kappa-B and JNK. Plays a role in the regulation of cell survival and apoptosis. The heterotrimer formed by TRAF1 and TRAF2 is part of a E3 ubiquitin-protein ligase complex that promotes ubiquitination of target proteins, such as MAP3K14. The TRAF1/TRAF2 complex recruits the antiapoptotic E3 protein-ubiquitin ligases BIRC2 and BIRC3 to TNFRSF1B/TNFR2","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/Q13077/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TRAF1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TRAF1","total_profiled":1310},"omim":[{"mim_id":"615614","title":"MMS22-LIKE PROTEIN; MMS22L","url":"https://www.omim.org/entry/615614"},{"mim_id":"613197","title":"TRAF-TYPE ZINC FINGER DOMAIN-CONTAINING 1; TRAFD1","url":"https://www.omim.org/entry/613197"},{"mim_id":"611749","title":"ZINC FINGER RANBP2-TYPE DOMAIN-CONTAINING PROTEIN 1; ZRANB1","url":"https://www.omim.org/entry/611749"},{"mim_id":"611748","title":"OTU DOMAIN-CONTAINING PROTEIN 7B; OTUD7B","url":"https://www.omim.org/entry/611748"},{"mim_id":"611211","title":"RECEPTOR EXPRESSED IN LYMPHOID TISSUES; RELT","url":"https://www.omim.org/entry/611211"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TRAF1"},"hgnc":{"alias_symbol":["EBI6"],"prev_symbol":[]},"alphafold":{"accession":"Q13077","domains":[{"cath_id":"2.60.210.10","chopping":"264-413","consensus_level":"high","plddt":96.188,"start":264,"end":413}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13077","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13077-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13077-F1-predicted_aligned_error_v6.png","plddt_mean":79.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TRAF1","jax_strain_url":"https://www.jax.org/strain/search?query=TRAF1"},"sequence":{"accession":"Q13077","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13077.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13077/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13077"}},"corpus_meta":[{"pmid":"9733516","id":"PMC_9733516","title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9733516","citation_count":2440,"is_preprint":false},{"pmid":"17804836","id":"PMC_17804836","title":"TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.","date":"2007","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17804836","citation_count":675,"is_preprint":false},{"pmid":"8943365","id":"PMC_8943365","title":"Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8943365","citation_count":424,"is_preprint":false},{"pmid":"8692885","id":"PMC_8692885","title":"The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8692885","citation_count":369,"is_preprint":false},{"pmid":"17880261","id":"PMC_17880261","title":"A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.","date":"2007","source":"PLoS medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17880261","citation_count":223,"is_preprint":false},{"pmid":"9032281","id":"PMC_9032281","title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032281","citation_count":185,"is_preprint":false},{"pmid":"20385093","id":"PMC_20385093","title":"Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20385093","citation_count":174,"is_preprint":false},{"pmid":"11672546","id":"PMC_11672546","title":"TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.","date":"2001","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11672546","citation_count":158,"is_preprint":false},{"pmid":"9151858","id":"PMC_9151858","title":"Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.","date":"1997","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9151858","citation_count":146,"is_preprint":false},{"pmid":"10383449","id":"PMC_10383449","title":"The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383449","citation_count":144,"is_preprint":false},{"pmid":"18523273","id":"PMC_18523273","title":"ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18523273","citation_count":133,"is_preprint":false},{"pmid":"12370254","id":"PMC_12370254","title":"Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling.","date":"2002","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12370254","citation_count":119,"is_preprint":false},{"pmid":"9151703","id":"PMC_9151703","title":"A regulatory role for TRAF1 in antigen-induced apoptosis of T cells.","date":"1997","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9151703","citation_count":116,"is_preprint":false},{"pmid":"26860405","id":"PMC_26860405","title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.","date":"2016","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/26860405","citation_count":115,"is_preprint":false},{"pmid":"24284943","id":"PMC_24284943","title":"TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal death.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24284943","citation_count":105,"is_preprint":false},{"pmid":"14585960","id":"PMC_14585960","title":"Discrete functions of TRAF1 and TRAF2 in Drosophila melanogaster mediated by c-Jun N-terminal kinase and NF-kappaB-dependent signaling pathways.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14585960","citation_count":98,"is_preprint":false},{"pmid":"35538475","id":"PMC_35538475","title":"N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma.","date":"2022","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35538475","citation_count":93,"is_preprint":false},{"pmid":"17332487","id":"PMC_17332487","title":"TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.","date":"2007","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17332487","citation_count":93,"is_preprint":false},{"pmid":"30619326","id":"PMC_30619326","title":"TRAF1 Signaling in Human Health and Disease.","date":"2018","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30619326","citation_count":88,"is_preprint":false},{"pmid":"9168896","id":"PMC_9168896","title":"Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9168896","citation_count":86,"is_preprint":false},{"pmid":"22570473","id":"PMC_22570473","title":"Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22570473","citation_count":80,"is_preprint":false},{"pmid":"18432273","id":"PMC_18432273","title":"STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians.","date":"2008","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18432273","citation_count":80,"is_preprint":false},{"pmid":"10544244","id":"PMC_10544244","title":"TRAF1 is a TNF inducible regulator of NF-kappaB activation.","date":"1999","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10544244","citation_count":77,"is_preprint":false},{"pmid":"16891304","id":"PMC_16891304","title":"The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16891304","citation_count":75,"is_preprint":false},{"pmid":"21905002","id":"PMC_21905002","title":"Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.","date":"2012","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/21905002","citation_count":70,"is_preprint":false},{"pmid":"18625278","id":"PMC_18625278","title":"Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.","date":"2008","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18625278","citation_count":70,"is_preprint":false},{"pmid":"25996949","id":"PMC_25996949","title":"TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/25996949","citation_count":70,"is_preprint":false},{"pmid":"14981539","id":"PMC_14981539","title":"Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14981539","citation_count":69,"is_preprint":false},{"pmid":"25566937","id":"PMC_25566937","title":"A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.","date":"2015","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25566937","citation_count":67,"is_preprint":false},{"pmid":"8943059","id":"PMC_8943059","title":"Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8943059","citation_count":64,"is_preprint":false},{"pmid":"27893701","id":"PMC_27893701","title":"The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27893701","citation_count":63,"is_preprint":false},{"pmid":"11098060","id":"PMC_11098060","title":"TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11098060","citation_count":61,"is_preprint":false},{"pmid":"10692572","id":"PMC_10692572","title":"Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10692572","citation_count":60,"is_preprint":false},{"pmid":"20421522","id":"PMC_20421522","title":"Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.","date":"2010","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/20421522","citation_count":57,"is_preprint":false},{"pmid":"12502848","id":"PMC_12502848","title":"TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12502848","citation_count":57,"is_preprint":false},{"pmid":"22184633","id":"PMC_22184633","title":"Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22184633","citation_count":56,"is_preprint":false},{"pmid":"26673966","id":"PMC_26673966","title":"A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels.","date":"2015","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26673966","citation_count":53,"is_preprint":false},{"pmid":"17197926","id":"PMC_17197926","title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.","date":"2007","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17197926","citation_count":52,"is_preprint":false},{"pmid":"19433411","id":"PMC_19433411","title":"The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19433411","citation_count":50,"is_preprint":false},{"pmid":"16323247","id":"PMC_16323247","title":"TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16323247","citation_count":50,"is_preprint":false},{"pmid":"34749775","id":"PMC_34749775","title":"DNMT1-induced miR-378a-3p silencing promotes angiogenesis via the NF-κB signaling pathway by targeting TRAF1 in hepatocellular carcinoma.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34749775","citation_count":49,"is_preprint":false},{"pmid":"19540595","id":"PMC_19540595","title":"TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.","date":"2009","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19540595","citation_count":48,"is_preprint":false},{"pmid":"34759347","id":"PMC_34759347","title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34759347","citation_count":47,"is_preprint":false},{"pmid":"29748372","id":"PMC_29748372","title":"TRAF1 Is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29748372","citation_count":46,"is_preprint":false},{"pmid":"17633014","id":"PMC_17633014","title":"TRAF1 and its biological functions.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17633014","citation_count":45,"is_preprint":false},{"pmid":"23999969","id":"PMC_23999969","title":"Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma.","date":"2013","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23999969","citation_count":45,"is_preprint":false},{"pmid":"10544141","id":"PMC_10544141","title":"The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.","date":"1999","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/10544141","citation_count":44,"is_preprint":false},{"pmid":"31650881","id":"PMC_31650881","title":"TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1-JNK/p38 Signaling.","date":"2019","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/31650881","citation_count":43,"is_preprint":false},{"pmid":"12754742","id":"PMC_12754742","title":"Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.","date":"2003","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12754742","citation_count":43,"is_preprint":false},{"pmid":"18593758","id":"PMC_18593758","title":"The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis.","date":"2008","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18593758","citation_count":43,"is_preprint":false},{"pmid":"25321474","id":"PMC_25321474","title":"TRAF1 is a key mediator for hepatic ischemia/reperfusion injury.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25321474","citation_count":42,"is_preprint":false},{"pmid":"17405906","id":"PMC_17405906","title":"NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17405906","citation_count":42,"is_preprint":false},{"pmid":"10657935","id":"PMC_10657935","title":"Tumor necrosis factor-alpha-induced lung cell expression of antiapoptotic genes TRAF1 and cIAP2.","date":"2000","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10657935","citation_count":41,"is_preprint":false},{"pmid":"12023442","id":"PMC_12023442","title":"TRAF1: lord without a RING.","date":"2002","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/12023442","citation_count":40,"is_preprint":false},{"pmid":"25533804","id":"PMC_25533804","title":"A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation.","date":"2014","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/25533804","citation_count":39,"is_preprint":false},{"pmid":"21968398","id":"PMC_21968398","title":"TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey.","date":"2011","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21968398","citation_count":39,"is_preprint":false},{"pmid":"15644776","id":"PMC_15644776","title":"TRAF1 expression and c-Rel activation are useful adjuncts in distinguishing classical Hodgkin lymphoma from a subset of morphologically or immunophenotypically similar lymphomas.","date":"2005","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15644776","citation_count":38,"is_preprint":false},{"pmid":"19116907","id":"PMC_19116907","title":"Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis.","date":"2009","source":"Arthritis and rheumatism","url":"https://pubmed.ncbi.nlm.nih.gov/19116907","citation_count":38,"is_preprint":false},{"pmid":"30524877","id":"PMC_30524877","title":"TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.","date":"2017","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/30524877","citation_count":37,"is_preprint":false},{"pmid":"12709429","id":"PMC_12709429","title":"Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12709429","citation_count":36,"is_preprint":false},{"pmid":"18429822","id":"PMC_18429822","title":"Negative regulation of constitutive NF-kappaB and JNK signaling by PKN1-mediated phosphorylation of TRAF1.","date":"2008","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/18429822","citation_count":35,"is_preprint":false},{"pmid":"19336421","id":"PMC_19336421","title":"Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19336421","citation_count":35,"is_preprint":false},{"pmid":"27151821","id":"PMC_27151821","title":"Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27151821","citation_count":33,"is_preprint":false},{"pmid":"30867239","id":"PMC_30867239","title":"4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30867239","citation_count":33,"is_preprint":false},{"pmid":"29207620","id":"PMC_29207620","title":"TXNDC5 is a cervical tumor susceptibility gene that stimulates cell migration, vasculogenic mimicry and angiogenesis by down-regulating SERPINF1 and TRAF1 expression.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29207620","citation_count":31,"is_preprint":false},{"pmid":"24952347","id":"PMC_24952347","title":"DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-)methylation of TRAF1.","date":"2014","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/24952347","citation_count":30,"is_preprint":false},{"pmid":"28470428","id":"PMC_28470428","title":"Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis.","date":"2017","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/28470428","citation_count":29,"is_preprint":false},{"pmid":"11028545","id":"PMC_11028545","title":"Inhibited neutrophil apoptosis: proteasome dependent NF-kappaB translocation is required for TRAF-1 synthesis.","date":"2000","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/11028545","citation_count":28,"is_preprint":false},{"pmid":"16352630","id":"PMC_16352630","title":"TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45.","date":"2005","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16352630","citation_count":27,"is_preprint":false},{"pmid":"22196377","id":"PMC_22196377","title":"Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population.","date":"2011","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22196377","citation_count":26,"is_preprint":false},{"pmid":"20856938","id":"PMC_20856938","title":"Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20856938","citation_count":25,"is_preprint":false},{"pmid":"11181075","id":"PMC_11181075","title":"Caspase-cleaved TRAF1 negatively regulates the antiapoptotic signals of TRAF2 during TNF-induced cell death.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11181075","citation_count":25,"is_preprint":false},{"pmid":"20822712","id":"PMC_20822712","title":"Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis.","date":"2010","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/20822712","citation_count":24,"is_preprint":false},{"pmid":"11118894","id":"PMC_11118894","title":"Dynamic expression of Drosophila TRAF1 during embryogenesis and larval development.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11118894","citation_count":23,"is_preprint":false},{"pmid":"37664606","id":"PMC_37664606","title":"Elabela inhibits TRAF1/NF-κB induced oxidative DNA damage to promote diabetic foot ulcer wound healing.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37664606","citation_count":23,"is_preprint":false},{"pmid":"22810054","id":"PMC_22810054","title":"Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.","date":"2012","source":"Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22810054","citation_count":23,"is_preprint":false},{"pmid":"19401279","id":"PMC_19401279","title":"Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.","date":"2009","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/19401279","citation_count":23,"is_preprint":false},{"pmid":"34627385","id":"PMC_34627385","title":"SPION-MSCs enhance therapeutic efficacy in sepsis by regulating MSC-expressed TRAF1-dependent macrophage polarization.","date":"2021","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/34627385","citation_count":23,"is_preprint":false},{"pmid":"17328785","id":"PMC_17328785","title":"TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation.","date":"2007","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17328785","citation_count":21,"is_preprint":false},{"pmid":"17392826","id":"PMC_17392826","title":"Differential expression of TRAF1 aids in the distinction of cutaneous CD30-positive lymphoproliferations.","date":"2007","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17392826","citation_count":21,"is_preprint":false},{"pmid":"29657313","id":"PMC_29657313","title":"Curcumin Attenuates Inflammation in a Severe Acute Pancreatitis Animal Model by Regulating TRAF1/ASK1 Signaling.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/29657313","citation_count":20,"is_preprint":false},{"pmid":"27060717","id":"PMC_27060717","title":"The Upregulation of TRAF1 Induced by Helicobacter pylori Plays an Antiapoptotic Effect on the Infected Cells.","date":"2016","source":"Helicobacter","url":"https://pubmed.ncbi.nlm.nih.gov/27060717","citation_count":20,"is_preprint":false},{"pmid":"35194031","id":"PMC_35194031","title":"FXR1 can bind with the CFIm25/CFIm68 complex and promote the progression of urothelial carcinoma of the bladder by stabilizing TRAF1 mRNA.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35194031","citation_count":20,"is_preprint":false},{"pmid":"29093082","id":"PMC_29093082","title":"According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.","date":"2018","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/29093082","citation_count":19,"is_preprint":false},{"pmid":"12782762","id":"PMC_12782762","title":"Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.","date":"2003","source":"Molecular pathology : MP","url":"https://pubmed.ncbi.nlm.nih.gov/12782762","citation_count":19,"is_preprint":false},{"pmid":"20030635","id":"PMC_20030635","title":"The TRAF1/C5 locus confers risk for familial and severe alopecia areata.","date":"2009","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/20030635","citation_count":19,"is_preprint":false},{"pmid":"9300817","id":"PMC_9300817","title":"Organization of the human tumour necrosis factor receptor-associated factor 1 (TRAF1) gene and mapping to chromosome 9q33-34.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9300817","citation_count":18,"is_preprint":false},{"pmid":"11395135","id":"PMC_11395135","title":"Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus.","date":"2000","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11395135","citation_count":18,"is_preprint":false},{"pmid":"23321589","id":"PMC_23321589","title":"Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23321589","citation_count":18,"is_preprint":false},{"pmid":"32982301","id":"PMC_32982301","title":"PRDX1 is a Tumor Suppressor for Nasopharyngeal Carcinoma by Inhibiting PI3K/AKT/TRAF1 Signaling.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32982301","citation_count":17,"is_preprint":false},{"pmid":"30173777","id":"PMC_30173777","title":"Mir-483 inhibits colon cancer cell proliferation and migration by targeting TRAF1.","date":"2018","source":"The Kaohsiung journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30173777","citation_count":16,"is_preprint":false},{"pmid":"28131816","id":"PMC_28131816","title":"TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28131816","citation_count":16,"is_preprint":false},{"pmid":"32093731","id":"PMC_32093731","title":"TRAF1 suppresses antifungal immunity through CXCL1-mediated neutrophil recruitment during Candida albicans intradermal infection.","date":"2020","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/32093731","citation_count":16,"is_preprint":false},{"pmid":"10499814","id":"PMC_10499814","title":"Structure of the murine TRAF1 gene.","date":"1999","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10499814","citation_count":16,"is_preprint":false},{"pmid":"22820624","id":"PMC_22820624","title":"Associations between TNFSF4 and TRAF1-C5 gene polymorphisms and systemic lupus erythematosus: a meta-analysis.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22820624","citation_count":15,"is_preprint":false},{"pmid":"30560327","id":"PMC_30560327","title":"miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.","date":"2018","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30560327","citation_count":15,"is_preprint":false},{"pmid":"28155233","id":"PMC_28155233","title":"Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.","date":"2017","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/28155233","citation_count":15,"is_preprint":false},{"pmid":"24321457","id":"PMC_24321457","title":"A single nucleotide polymorphism of TRAF1 predicts the clinical response to anti-TNF treatment in Japanese patients with rheumatoid arthritis.","date":"2013","source":"Clinical and experimental rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/24321457","citation_count":15,"is_preprint":false},{"pmid":"20413583","id":"PMC_20413583","title":"Translation of TRAF1 is regulated by IRES-dependent mechanism and stimulated by vincristine.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20413583","citation_count":14,"is_preprint":false},{"pmid":"27536202","id":"PMC_27536202","title":"Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients.","date":"2016","source":"Central-European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27536202","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53845,"output_tokens":9109,"usd":0.149085,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19009,"output_tokens":4827,"usd":0.10786,"stage2_stop_reason":"end_turn"},"total_usd":0.256945,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"NF-κB transcriptionally induces TRAF1, TRAF2, c-IAP1, and c-IAP2; these proteins act cooperatively to suppress caspase-8 activation and block TNF-α-mediated apoptosis at the earliest checkpoint.\",\n      \"method\": \"NF-κB reporter assays, cotransfection/overexpression, caspase-8 activation assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional experiments with reporter assays and caspase activity readouts, widely replicated across subsequent literature\",\n      \"pmids\": [\"9733516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"TRAF1, TRAF2, and TRAF3 bind a single PXQXT/S core motif in the LMP1 cytoplasmic C-terminus (aa 199–214); in EBV-transformed B cells most TRAF1 and TRAF3 is associated with LMP1. TRAF1 coactivates NF-κB with LMP1 via TRAF1/TRAF2 heteroaggregates; dominant-negative TRAF2 blocks this, and TRAF3 is a negative modulator.\",\n      \"method\": \"Co-immunoprecipitation, alanine/deletion mutagenesis, NF-κB reporter cotransfection, EBV-transformed B cell fractionation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — mutagenesis mapping + reciprocal co-IP in primary EBV-transformed cells, replicated by multiple labs\",\n      \"pmids\": [\"8943365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"A20 interacts with the conserved C-terminal TRAF domain of TRAF1 and TRAF2 via its N-terminal half; A20's C-terminal zinc finger domain inhibits TRAF2-mediated NF-κB activation, identifying a two-domain feedback inhibitor recruited to the TRAF1/TRAF2 complex.\",\n      \"method\": \"Co-immunoprecipitation, deletion/mutational analysis, NF-κB reporter cotransfection assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal binding assays with mutagenesis, functional NF-κB readout, replicated by other labs\",\n      \"pmids\": [\"8692885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD30 cytoplasmic domain contains two TRAF-binding motifs: membrane-proximal motif 576MLSVEEEG583 binds TRAF1 and TRAF2, while 558PHYPEQET565 binds TRAF2 and TRAF3. Coexpression of TRAF1 or TRAF2 (but not TRAF3) augments CD30 domain 2-mediated NF-κB activation; dominant-negative TRAF1 or TRAF2 inhibits this.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, NF-κB reporter cotransfection, deletion/dominant-negative analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus reciprocal co-IP plus functional NF-κB assay with dominant negatives, independently confirmed by multiple labs\",\n      \"pmids\": [\"9032281\", \"9168896\", \"8943059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structures of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2 complexes show that a TRAF2 trimer contacts cIAP2 via two chains; TRAF1 and TRAF2 preferentially form a TRAF1:(TRAF2)₂ heterotrimer that binds cIAP2 more strongly than TRAF2 alone. TRAF1 alone binds cIAP2 very weakly. Key interface residues confirmed by mutagenesis.\",\n      \"method\": \"X-ray crystallography, solution binding assays, site-directed mutagenesis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with mutagenesis validation in single rigorous study\",\n      \"pmids\": [\"20385093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TRAF1-deficient mice show enhanced TNF signaling: TRAF1⁻/⁻ T cells respond to TNF via TNFR2 (p75) but not TNFR1 (p55) with hyperproliferation and elevated NF-κB/AP-1 activity, and skin is hypersensitive to TNF-induced necrosis, demonstrating TRAF1 is a negative regulator of TNFR2-mediated TNF signaling.\",\n      \"method\": \"Knockout mouse generation, T cell proliferation assays, NF-κB/AP-1 signaling assays, in vivo skin necrosis model\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with multiple orthogonal phenotypic readouts and receptor specificity defined\",\n      \"pmids\": [\"11672546\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TRAF1 displaces TRAF2 from lipid rafts/detergent-insoluble fractions and prevents stimulus-dependent TRAF2 degradation, thereby sustaining TRAF2-dependent signaling over time. TRAF1⁻/⁻ dendritic cells show attenuated responses to secondary TRAF2-dependent stimulation and increased TRAF2 degradation.\",\n      \"method\": \"Lipid raft fractionation, co-immunoprecipitation, TRAF1-KO dendritic cell signaling assays, RING-finger domain swap constructs\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (fractionation, KO cells, domain swap) in single study\",\n      \"pmids\": [\"12370254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TRAF1 (but not TRAF2–6) is cleaved by caspase-8 at site ¹⁶⁰LEVD¹⁶³ during TNF-α- and Fas-induced apoptosis, generating a C-terminal fragment that suppresses NF-κB activation and enhances TNF receptor-1-mediated apoptosis.\",\n      \"method\": \"In vitro caspase cleavage assays, in vivo apoptosis induction, site-directed mutagenesis of cleavage site, NF-κB reporter assays, overexpression in HEK293T and HT1080 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro cleavage mapping with mutagenesis plus in vivo confirmation and functional readout\",\n      \"pmids\": [\"11098060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TRAF1 is cleaved after Asp-163 during Fas ligand-induced apoptosis; the C-terminal cleavage product acts as a dominant-negative form of TRAF1 that blocks TNF-induced NF-κB activation, providing a pro-apoptotic amplification mechanism.\",\n      \"method\": \"Apoptosis induction, Western blot cleavage analysis, NF-κB reporter assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, functional reporter assay; corroborates PMID 11098060 finding\",\n      \"pmids\": [\"10692572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Caspase-derived C-terminal TRAF1 fragment (TRAF1-164–416) acts as a general inhibitor of NF-κB activation by directly associating with the IKK complex via the N-TRAF domain, whereas full-length TRAF1 modulates NF-κB differentially across TNF receptors. Full-length TRAF1 and the cleavage fragment are both constitutively associated with IKK.\",\n      \"method\": \"Co-immunoprecipitation with IKK complex, NF-κB reporter assays, IKK kinase assays, overexpression of TRAF domain fragments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with IKK plus kinase assay plus functional reporter, single lab\",\n      \"pmids\": [\"12709429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Caspase-8-generated C-terminal TRAF1 fragment co-immunoprecipitates with TRAF2 released from the TNFR1 complex during prolonged TNF treatment, sequestering TRAF2 and thereby reducing its anti-apoptotic signaling.\",\n      \"method\": \"Co-immunoprecipitation from TNF-stimulated cells, overexpression of TRAF1-c fragment, cell death assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single co-IP experiment in intact cells corroborating prior cleavage findings\",\n      \"pmids\": [\"11181075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TRAF1 promoter contains functional NF-κB binding sites; TNF-R1, CD40, and IL-1R trigger NF-κB-dependent TRAF1 transcription. Overexpressed TRAF1 prolongs TNF-induced JNK activation while a deletion mutant lacking the N-terminal region inhibits TNF-induced NF-κB and JNK activation.\",\n      \"method\": \"EMSA, promoter-reporter gene assays, RNase protection, transfection of deletion mutants\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA + promoter reporter + dominant-negative functional assay in single lab\",\n      \"pmids\": [\"10383449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Overexpression of TRAF1 in HEK293T cells completely prevented NF-κB activation induced by TNF, IL-1, overexpression of TRAF2, or TRAF6, identifying TRAF1 as a negative regulator of NF-κB pathways. TNF-induced TRAF1 upregulation was blocked by the proteasome inhibitor MG-132.\",\n      \"method\": \"Transfection/overexpression, NF-κB reporter assays, pharmacological inhibition\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — functional reporter assay with overexpression, single lab\",\n      \"pmids\": [\"10544244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TRAF1 is required for 4-1BB-mediated CD8 T cell survival in vivo; TRAF1-deficient CD8 T cells fail to activate ERK downstream of 4-1BB, show reduced Bcl-xL upregulation and elevated Bim, resulting in impaired survival during viral infection. ERK inhibition downstream of 4-1BB in wild-type cells phenocopies TRAF1 deficiency.\",\n      \"method\": \"TRAF1-KO mice, viral infection models, intracellular signaling assays (ERK activation), Bcl-xL/Bim Western blot, pharmacological ERK inhibition\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in vivo model with orthogonal pharmacological validation and defined molecular pathway\",\n      \"pmids\": [\"18523273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TRAF1 is required for maximal classical NF-κB activation downstream of 4-1BB; TRAF1 also restricts constitutive NIK activity in activated T cells by participating in the cIAP1/2:TRAF2:TRAF3:NIK complex. 4-1BB stimulation induces cIAP1-dependent TRAF3 degradation to activate the alternative NF-κB pathway, and this requires TRAF1.\",\n      \"method\": \"siRNA knockdown of NIK, TRAF1-KO primary T cells, NF-κB pathway reporter assays, Western blot for NIK/TRAF3/cIAP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus siRNA epistasis with multiple pathway readouts in single rigorous study\",\n      \"pmids\": [\"22570473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Increased neuronal TRAF1 after stroke correlates with elevated neuronal death and enlarged ischemic lesions; TRAF1 deficiency is neuroprotective. TRAF1 directly interacts with ASK1 to activate the JNK pro-death pathway and inhibit the Akt survival pathway.\",\n      \"method\": \"Genetic KO/overexpression in mouse stroke model, co-immunoprecipitation for TRAF1-ASK1 interaction, JNK and Akt pathway Western blots\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic approaches plus direct co-IP demonstrating TRAF1-ASK1 physical interaction with pathway readouts\",\n      \"pmids\": [\"24284943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TRAF1 promotes hepatic steatosis, insulin resistance, and inflammation through enhancing ASK1-mediated P38/JNK cascade activation; ASK1 inhibition abolishes these effects. Demonstrated using TRAF1-KO and liver-specific TRAF1 overexpression mice.\",\n      \"method\": \"Global TRAF1 KO and liver-specific overexpression mouse models, HFD/ob-ob obesity models, in vivo ASK1 inhibitor treatment, P38/JNK pathway Western blots\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic gain- and loss-of-function with pharmacological epistasis confirming TRAF1→ASK1 axis\",\n      \"pmids\": [\"26860405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The TRAF1 MATH domain binds directly to three LUBAC components (SHARPIN, HOIP, HOIL-1), interfering with NEMO linear ubiquitination and thereby decreasing NF-κB activation and cytokine production independently of TNF. This negative regulation of TLR signaling is distinct from its TNFR superfamily role.\",\n      \"method\": \"Direct binding assays, co-immunoprecipitation of TRAF1-LUBAC complex, NEMO ubiquitination assays, Traf1-KO mice in LPS septic shock model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding mapping with co-IP, functional ubiquitination assay, and in vivo KO validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"27893701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"LMP1 TES1 domain signaling induces TRAF1 association with LUBAC and stimulates M1-linked polyubiquitin chain attachment to TRAF1 complexes; TRAF2 (but not cIAP1/2) is required for LUBAC recruitment. LMP1/TRAF1 complexes are also decorated by K63-linked polyubiquitin chains, and TRAF2 is a K63-Ub chain target. TRAF1 depletion markedly impairs LCL growth.\",\n      \"method\": \"Proteomic analysis of immunopurified TRAF1 complexes, M1/K63 polyubiquitin chain detection, TRAF1/HOIP knockdown with proliferation assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mass spectrometry interactome plus orthogonal ubiquitin chain assays plus functional knockdown readout\",\n      \"pmids\": [\"25996949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TRAF1 interacts with the TIR domain adaptor TRIF via its TRAF-C domain; overexpression of TRAF1 inhibits TRIF- and TLR3-mediated NF-κB, ISRE, and IFN-β promoter activation. TRIF overexpression causes caspase-dependent cleavage of TRAF1; the cleaved N-terminal fragment (but not C-terminal) mediates inhibition, and mutation of the caspase cleavage site abolishes inhibition.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, domain mapping, NF-κB/ISRE/IFN-β reporter assays, caspase cleavage mutants\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus co-IP plus mutagenesis with functional reporters, single lab\",\n      \"pmids\": [\"16323247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TRAF1 critically regulates TRAF2-dependent JNK activation downstream of LMP1 TRAF-binding domain in a cell-type-specific manner; in TRAF1-negative epithelial cells reconstitution of TRAF1 expression restores LMP1-induced JNK activation. This TRAF1 requirement is specific to LMP1's TRAF-binding domain and is not shared by CD40's homologous region.\",\n      \"method\": \"TRAF1-positive vs -negative cell lines, TRAF1 reconstitution, dominant-negative TRAF constructs, JNK kinase assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type comparison with reconstitution and dominant-negative epistasis, single lab\",\n      \"pmids\": [\"12502848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKN1 phosphorylates TRAF1 in vitro and in vivo; this phosphorylation is required to attenuate constitutive IKK/JNK activity in unstimulated cells. Mutation of the TRAF1 phospho-acceptor residue abrogates PKN1-dependent TRAF1 recruitment to TNFR2. The stoichiometric ratio of TRAF1:TRAF2 heteromeric complexes at TNFR2 controls tonic JNK and IKK activity.\",\n      \"method\": \"In vitro kinase assay with PKN1 and TRAF1, in vivo phosphorylation analysis, phospho-acceptor mutagenesis, co-immunoprecipitation with TNFR2, IKK/JNK activity assays\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Weak — in vitro kinase assay plus in vivo phosphorylation plus mutagenesis, but single lab\",\n      \"pmids\": [\"18429822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Phorbol ester-mediated TRAF1 induction in colon cancer cells proceeds through a Ca²⁺-dependent PKC/Raf-1/MEK/ERK/NF-κB pathway; site-specific mutagenesis of NF-κB sites in the TRAF1 promoter (especially the most proximal site) significantly decreases phorbol ester-driven TRAF1 transcription.\",\n      \"method\": \"PKC inhibitors, MEK/ERK inhibitors, dominant-negative Raf-1 transfection, NF-κB site mutagenesis in TRAF1 promoter-reporter constructs\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibitors plus dominant-negative plus promoter mutagenesis, single lab\",\n      \"pmids\": [\"14981539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Overexpression of TRAF1 in transgenic mice inhibits antigen-induced apoptosis of CD8⁺ T lymphocytes, establishing a biological role for TRAF1 as a regulator of apoptotic signals downstream of TNFR2.\",\n      \"method\": \"TRAF1 transgenic mice, antigen-induced apoptosis assay in CD8 T cells\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic gain-of-function model with defined apoptosis readout, single lab\",\n      \"pmids\": [\"9151703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TRAF1 associates with NIP45 (NFAT-interacting protein) in the cytoplasm and prevents its nuclear translocation; TRAF1-deficient T cells show elevated nuclear NIP45 and increased Th2 cytokine production, indicating TRAF1 limits Th2 differentiation by retaining NIP45 in the cytoplasm.\",\n      \"method\": \"TRAF1-KO mouse model, Th2 cytokine measurement, subcellular fractionation/nuclear NIP45 Western blot, in vitro T cell stimulation\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus biochemical co-localization with defined functional consequence, single lab\",\n      \"pmids\": [\"16352630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD40 engagement induces TRAF1 gene transcription in B lymphocytes through two enhancer regions: an upstream region (~2 kb from start site) containing a single critical NF-κB site (mutation abolishes CD40-driven TRAF1 transcription) and an intronic enhancer (between exons 5 and 6) with NF-κB and AP-1 sites.\",\n      \"method\": \"CD40 ligation, reporter gene assays, NF-κB/AP-1 site mutagenesis, B lymphocyte transfections\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutagenesis with functional reporter, single lab\",\n      \"pmids\": [\"11395135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure of the TRAF1 TRAF domain (TRAF-N coiled-coil + TRAF-C) reveals that the TRAF-N coiled-coil domain is critical for trimer formation and protein stability; conserved TRAF-C surface residues constitute binding hotspots for interaction with signaling molecules.\",\n      \"method\": \"X-ray crystallography, biochemical trimer formation assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure of isolated domain, single lab, limited mutagenesis\",\n      \"pmids\": [\"27151821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structure of TRAF1 TRAF domain in complex with TANK peptide shows TANK binds TRAF1 using the minor consensus motif Px(Q/E)xT; quantitative binding experiments show TANK interacts with TRAF1 and TRAF2 with similar micromolar affinity.\",\n      \"method\": \"X-ray crystallography (PDB: 5H10), quantitative binding assays\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structure with quantitative binding, single lab, no mutagenesis validation\",\n      \"pmids\": [\"28155233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRAF1 is critical for solar UV-induced ERK5 phosphorylation and AP-1 (c-Fos/c-Jun) expression in skin carcinogenesis; TRAF1 enhances ubiquitination of ERK5 on lysine 184, which is necessary for ERK5 kinase activity. TRAF1-KO mice show significant inhibition of skin tumor formation.\",\n      \"method\": \"TRAF1-KO mouse carcinogenesis model, ERK5 ubiquitination assays, phosphorylation/AP-1 Western blots, site-specific ubiquitin acceptor mutagenesis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in vivo model with ERK5 ubiquitination mapping, single lab\",\n      \"pmids\": [\"28131816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRAF1 affects TRAF2-mediated K48-linked ubiquitination of BRAF; loss of TRAF1 decelerated tumor invasion in a urethane-induced lung carcinogenesis model, positioning TRAF1 as a regulator of the BRAF/MEK/ERK signaling pathway in NSCLC.\",\n      \"method\": \"TRAF1 overexpression/knockdown in cancer cells, ubiquitination assays for BRAF, in vivo lung carcinogenesis mouse model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ubiquitination assay plus in vivo KO tumor model, single lab\",\n      \"pmids\": [\"29748372\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 interacts with IKK2 (identified by yeast two-hybrid using IKK2 C-terminal aa 466–756 as bait, binding TRAF1 N-terminal aa 1–228); confirmed by mammalian two-hybrid and co-immunoprecipitation. TRAF1 can both activate and inhibit IKK2 and NF-κB depending on dose; TRAF1 affects TRAF2 clustering in a dose-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, mammalian two-hybrid, co-immunoprecipitation, NF-κB reporter assays, fluorescence-tagged co-expression\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two-hybrid plus co-IP plus functional assays, single lab\",\n      \"pmids\": [\"20856938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 deficiency in TRAF1⁻/⁻/LDLR⁻/⁻ mice attenuates atherosclerosis; mechanistically, TRAF1 deficiency in endothelial cells and monocytes reduces cell adhesion, actin polymerization, CD29 expression, and ICAM-1/VCAM-1 expression. Bone marrow transplantation reveals contributions from both hematopoietic and vascular resident TRAF1.\",\n      \"method\": \"Double-KO mouse atherosclerosis model, bone marrow transplantation, static/dynamic adhesion assays, siRNA in human cells\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus BM transplantation plus siRNA mechanistic validation, single lab\",\n      \"pmids\": [\"20421522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TRAF1 mRNA translation is regulated by an IRES element located within 572 nt upstream of the AUG start codon (critical element between nt −392 and −322); vincristine induces TRAF1 protein expression by regulating cytoplasmic localization of polypyrimidine tract binding protein to stimulate IRES-dependent translation.\",\n      \"method\": \"Reporter assays with IRES-containing 5'-UTR constructs, deletion mapping, polypyrimidine tract binding protein cytoplasmic localization assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with deletion mapping plus mechanistic protein localization link, single lab\",\n      \"pmids\": [\"20413583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A novel TRAF1-ALK fusion transcript (TRAF1 exon 6 fused to ALK exon 20) was identified in an anaplastic large cell lymphoma patient; the fusion protein was confirmed by Western blot, indicating TRAF1 can function as an ALK fusion partner driving lymphoma.\",\n      \"method\": \"Deep RNA sequencing, Sanger sequencing confirmation, Western blot for fusion protein\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single patient discovery, fusion protein confirmed by Western blot, no functional mechanistic studies in this paper\",\n      \"pmids\": [\"23999969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TRAF1 deficiency in endothelial cells enhances CD40L-induced IL-6 and MCP-1 expression, while TRAF2 and TRAF5 deficiency inhibit CD40L-inducible IL-6 but not MCP-1, demonstrating that TRAF1 has a negative regulatory role in CD40 signaling in endothelial cells.\",\n      \"method\": \"Endothelial cells from TRAF-1, -2, -5-deficient mice, cytokine ELISA, gene silencing in human ECs\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO cells plus siRNA in human cells with cytokine readout, single lab\",\n      \"pmids\": [\"17332487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DNMT3L forms a complex with DNMT3B and NF-κB p65 that controls DNA methylation at the TRAF1 promoter; TET3 is involved in demethylation of TRAF1, demonstrating dynamic methylation control of the TRAF1 locus.\",\n      \"method\": \"TF array binding assays, co-immunoprecipitation of DNMT3L/DNMT3B/p65 complex, bisulfite sequencing of TRAF1 promoter, TET3 functional assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complex co-IP plus bisulfite sequencing, single lab\",\n      \"pmids\": [\"24952347\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TGF-β induces posttranslational loss of TRAF1 protein from CD8 T cells, while IL-7 restores TRAF1 levels; loss of TRAF1 correlates with desensitization of 4-1BB signaling and T cell exhaustion during chronic LCMV infection. Transfer of TRAF1⁺ but not TRAF1⁻ memory T cells reduces viral load.\",\n      \"method\": \"Cytokine treatment of primary T cells with TRAF1 Western blot, LCMV chronic infection model, adoptive T cell transfer\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo LCMV model plus cytokine mechanistic studies plus adoptive transfer, single lab\",\n      \"pmids\": [\"22184633\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TRAF1 is a RING finger-lacking adaptor protein that forms TRAF1:(TRAF2)₂ heterotrimers and associates with TNFR superfamily members (TNFR2, CD30, CD40, 4-1BB, LMP1) via a PXQXT/S motif; it modulates canonical and alternative NF-κB, JNK, ERK, and Akt pathways both positively (sustaining TRAF2 stability and 4-1BB→ERK→Bcl-xL survival signals) and negatively (competing with TRAF2 at receptors, sequestering LUBAC from NEMO to dampen TLR-driven NF-κB, and generating a dominant-negative caspase-8 cleavage fragment that suppresses NF-κB and amplifies apoptosis), and also directly binds ASK1 to promote JNK-mediated cell death in ischemic and inflammatory contexts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TRAF1 is a RING finger-lacking adaptor of the TRAF family that couples TNF receptor superfamily members to NF-κB, JNK, ERK, and apoptotic signaling, acting as both a positive and negative modulator depending on receptor and dose [#5, #12]. It binds TNFR superfamily members and viral mimics through a PXQXT/S-type core motif, engaging LMP1, CD30, and other receptors, where it coactivates NF-κB largely as part of TRAF1/TRAF2 heteroaggregates [#1, #3]. Structurally, TRAF1 preferentially assembles into a TRAF1:(TRAF2)₂ heterotrimer whose TRAF-N coiled-coil drives trimerization and stability and whose TRAF-C surface forms the binding hotspot for partners such as cIAP2 and TANK; TRAF1 alone binds cIAP2 weakly, so its activity is largely exerted through TRAF2 [#4, #26, #27]. As a transcriptional target induced by NF-κB downstream of TNFR1, CD40, and IL-1R, TRAF1 participates with TRAF2 and cIAP1/2 in suppressing caspase-8 activation and blocking early TNF-induced apoptosis, and it stabilizes TRAF2 by displacing it from lipid rafts to sustain signaling over time [#0, #6, #25]. TRAF1 sets the threshold of multiple pathways: it restricts TNFR2-driven hyperproliferation and TNF-induced necrosis, dampens TLR-driven NF-κB by sequestering LUBAC components away from NEMO-directed linear ubiquitination, and limits constitutive NIK activity within the cIAP1/2:TRAF2:TRAF3:NIK complex [#5, #14, #17]. In CD8 T cells it is required for 4-1BB–driven ERK activation, Bcl-xL induction, and survival, defining a costimulatory survival function [#13]. Apoptotic caspase-8 cleavage at Asp-163 converts TRAF1 into a C-terminal dominant-negative fragment that associates with the IKK complex and sequesters released TRAF2, suppressing NF-κB and amplifying death signaling [#7, #9, #10]. TRAF1 also directly binds ASK1 to drive JNK-mediated, Akt-suppressing cell death in ischemic stroke and metabolic/inflammatory liver disease [#15, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that TRAF1 is recruited to receptor cytoplasmic tails through a defined short linear motif and signals as part of TRAF1/TRAF2 heteroaggregates, defining its mode of receptor engagement.\",\n      \"evidence\": \"Co-IP, mutagenesis mapping of the PXQXT/S motif in LMP1 and CD30, and NF-κB reporter assays in EBV-transformed B cells\",\n      \"pmids\": [\"8943365\", \"9032281\", \"9168896\", \"8943059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve stoichiometry or structural basis of TRAF1:TRAF2 heteromers\", \"Receptor selectivity rules between TRAF1, TRAF2, and TRAF3 not fully defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified A20 as a feedback inhibitor recruited to the TRAF1/TRAF2 complex, embedding TRAF1 in a negative-regulatory circuit of NF-κB.\",\n      \"evidence\": \"Co-IP, deletion analysis, and NF-κB reporter assays\",\n      \"pmids\": [\"8692885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct contribution of TRAF1 (versus TRAF2) to A20 docking unresolved\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placed TRAF1 in a cooperative anti-apoptotic module that blocks caspase-8 activation at the earliest TNF checkpoint, linking it functionally to cell survival.\",\n      \"evidence\": \"NF-κB reporter assays, cotransfection with TRAF2/cIAP1/cIAP2, and caspase-8 activation assays\",\n      \"pmids\": [\"9733516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of TRAF1 within the four-protein module not dissected\", \"Mechanism of caspase-8 suppression not defined at molecular level\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Showed that caspase cleavage at Asp-163 converts TRAF1 into a dominant-negative fragment, revealing a switch that amplifies apoptosis by suppressing NF-κB.\",\n      \"evidence\": \"In vitro caspase-8 cleavage mapping, cleavage-site mutagenesis, in vivo apoptosis, and NF-κB reporter assays\",\n      \"pmids\": [\"11098060\", \"10692572\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous abundance and kinetics of the fragment in physiological apoptosis unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined TRAF1 as a negative regulator restricting TNFR2-specific TNF signaling in vivo, distinguishing receptor-selective roles.\",\n      \"evidence\": \"TRAF1-KO mice, T cell proliferation and NF-κB/AP-1 assays, TNFR1/TNFR2 receptor discrimination, and in vivo skin necrosis model\",\n      \"pmids\": [\"11672546\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of TNFR2 versus TNFR1 selectivity not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Explained one positive function: TRAF1 sustains signaling by displacing TRAF2 from lipid rafts and preventing its stimulus-dependent degradation.\",\n      \"evidence\": \"Lipid raft fractionation, co-IP, TRAF1-KO dendritic cells, and RING-domain swap constructs\",\n      \"pmids\": [\"12370254\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation machinery acting on TRAF2 not identified\", \"How TRAF1 mechanistically blocks TRAF2 turnover unresolved\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mapped the cleavage fragment's inhibitory mechanism to direct constitutive association with the IKK complex via the N-TRAF domain.\",\n      \"evidence\": \"Co-IP with IKK, IKK kinase assays, NF-κB reporters, and TRAF-domain fragment overexpression\",\n      \"pmids\": [\"12709429\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; physiological relevance of constitutive IKK association not validated in primary cells\", \"Precise IKK subunit contact not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined a costimulatory survival function: TRAF1 is required for 4-1BB→ERK→Bcl-xL signaling that sustains CD8 T cell survival.\",\n      \"evidence\": \"TRAF1-KO mice, viral infection, ERK activation and Bcl-xL/Bim Westerns, and pharmacological ERK inhibition phenocopy\",\n      \"pmids\": [\"18523273\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct link between TRAF1 and ERK activation machinery not biochemically mapped\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided the structural basis for TRAF1's TRAF2-dependent activity, showing TRAF1:(TRAF2)₂ heterotrimers bind cIAP2 strongly while TRAF1 alone binds weakly.\",\n      \"evidence\": \"X-ray crystallography of TRAF2:cIAP2 and TRAF1:TRAF2:cIAP2, solution binding, and interface mutagenesis\",\n      \"pmids\": [\"20385093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of TRAF1 bound to receptor tails not solved\", \"Dynamics of heterotrimer assembly in cells not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed TRAF1 tunes both canonical and alternative NF-κB by enabling 4-1BB-driven classical activation while restricting constitutive NIK within the cIAP:TRAF2:TRAF3:NIK complex.\",\n      \"evidence\": \"TRAF1-KO primary T cells, NIK siRNA epistasis, and NIK/TRAF3/cIAP Westerns with reporter assays\",\n      \"pmids\": [\"22570473\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometric control of NIK degradation by TRAF1 not quantified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified a direct TRAF1–ASK1 interaction driving JNK-mediated death and Akt suppression, extending TRAF1 function to ischemic neuronal injury.\",\n      \"evidence\": \"Genetic KO/overexpression in mouse stroke model, TRAF1-ASK1 co-IP, and JNK/Akt Westerns\",\n      \"pmids\": [\"24284943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ASK1-binding region of TRAF1 not mapped\", \"Whether TRAF2 is required for the ASK1 interaction unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established that the TRAF1 MATH/TRAF-C domain binds LUBAC components to interfere with NEMO linear ubiquitination, defining a TNFR-independent brake on TLR-driven NF-κB.\",\n      \"evidence\": \"Direct binding assays to SHARPIN/HOIP/HOIL-1, co-IP, NEMO ubiquitination assays, and Traf1-KO LPS septic shock model\",\n      \"pmids\": [\"27893701\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative competition between TRAF1 and NEMO for LUBAC not measured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended the TRAF1→ASK1 axis to metabolic disease, showing TRAF1 promotes hepatic steatosis and insulin resistance via ASK1-dependent P38/JNK activation.\",\n      \"evidence\": \"Global KO and liver-specific overexpression mice, obesity models, and in vivo ASK1 inhibitor epistasis\",\n      \"pmids\": [\"26860405\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific contributions to hepatic phenotype not fully separated\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linked TRAF1 to oncogenic kinase signaling by promoting ERK5 K184 ubiquitination and TRAF2-mediated BRAF ubiquitination in carcinogenesis models.\",\n      \"evidence\": \"TRAF1-KO carcinogenesis models, ERK5/BRAF ubiquitination assays, and ubiquitin-acceptor mutagenesis\",\n      \"pmids\": [\"28131816\", \"29748372\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TRAF1 lacks intrinsic ubiquitin ligase activity; the responsible E3 (likely TRAF2/cIAP) not definitively assigned\", \"Single-lab findings per tumor context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TRAF1 dose, phosphorylation, and partner composition switch it between positive and negative signaling at a given receptor remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model integrating TRAF1:TRAF2 stoichiometry, PKN1 phosphorylation, and receptor context\", \"Structures of full-length receptor-bound TRAF1 complexes lacking\", \"In vivo relevance of caspase-cleavage fragment versus full-length TRAF1 not delineated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 3, 4, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 12, 14, 17]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [24, 6]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 5, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [13, 17, 36]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 7, 15, 23]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [28, 29, 18]}\n    ],\n    \"complexes\": [\n      \"TRAF1:(TRAF2)2 heterotrimer\",\n      \"cIAP1/2:TRAF2:TRAF3:NIK complex\",\n      \"LUBAC (SHARPIN/HOIP/HOIL-1) associated complex\",\n      \"IKK complex\"\n    ],\n    \"partners\": [\n      \"TRAF2\",\n      \"cIAP2\",\n      \"ASK1\",\n      \"HOIP\",\n      \"TANK\",\n      \"NIP45\",\n      \"IKK2\",\n      \"TRIF\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}